NCT04994860View on ClinicalTrials.gov

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

June 7, 2018

Study Completion Date

June 7, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

BIA 5-1058

Oral BIA 5-1058 (Zamicastat) 100 mg tablets

DRUG

Sildenafil

Oral Sildenafil ( Revatio) 20 mg film coated tablets

Trial Locations (1)

14050

PAREXEL International - Early Phase Clinical Unit - Berlin, Berlin

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT04994860 - Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil | Biotech Hunter | Biotech Hunter